Friday, February 19, 2016

Weekly Links February 19th, 2016



“MUST READ”
An old problem in a new age: Revisiting the clinical dilemma of misattributed paternity ☆ Clinical genetics has wrestled with the problem of misattributed paternity for decades. While there are no clear directives on policy, surveys suggest that gen…
Interview With President Barack Obama : Popular Science PS: Let’s talk about more-difficult science: Two of your biggest science initiatives have been to decode the brain and pioneer precision medicine.
TOOLS/TECHNIQUES
    • NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life science tools for translational research and molecular diagnostic products, today presented the first proof-of-concept data for its novel massively parallel single molecule sequencing chemistry, Hyb & SeqTM, at the Advances in Genome Biology and Technology (AGBT) Meeting
  • World Largest Genome Project & Global Leader in NGS Partner
World’s Largest Genome Sequencing Project partners with Global Leader in NGS Genomics England (UK) today announce a partnership with the Next-Generation Sequencing Giant, Illumina (US), to develop a platform that can be used to improve and automate …

HEALTH/MEDECINE
Human Complex Trait Genetics in the 21st Century I moved into the field of human complex trait genetics less than 20 years ago, from a background in quantitative genetics and animal breeding. Even in this period of time, major changes have occurred …

COMPANIES
    • Millidrop will use the fund to start producing trial runs of its first machine, the MilliDrop Analyzer. This machine uses millifluidics technology to culture and analyse micro-organisms.
The company is also under the Pierre-Gilles de Gennes Institute for Microfluidics (IPGG), which is serving as an incubator for MilliDrop.
At-Home Full Genome-Sequencing Is Now Just A Spit Tube Away DNA sequencing startup Sure Genomics wants to help you learn about your entire genome at the click of a button. Today, the startup opened up an at-home service to the public, enabling consu…

No comments:

Post a Comment